Spironolactone treatment in scleroderma--a double-blind therapy study.
D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D013148:Spironolactone / Q000627:therapeutic use*
D013148:Spironolactone